LEXICON PHARMACEUTICALS INC (LXRX)

US5288723027 - Common Stock

1.205  -0.01 (-1.23%)

After market: 1.22 +0.01 (+1.24%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

LEXICON PHARMACEUTICALS INC

NASDAQ:LXRX (11/4/2024, 8:21:55 PM)

After market: 1.22 +0.01 (+1.24%)

1.205

-0.01 (-1.23%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-32.68%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap435.60M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

LXRX Daily chart

Company Profile

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company is headquartered in The Woodlands, Texas and currently employs 285 full-time employees. The company went IPO on 2000-04-07. The firm is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The firm pipeline includes INPEFA (sotagliflozin), LX9211, and LX9851. Sotagliflozin is an orally delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally delivered small molecule compound that is being developed for the treatment of neuropathic pain. The firm is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. The firm is conducting preclinical development of LX9851, an orally delivered small molecule drug candidate, as a treatment for obesity and tool for weight management.

Company Info

LEXICON PHARMACEUTICALS INC

2445 Technology Forest Blvd, 11Th Floor

The Woodlands TEXAS 77381

P: 12818633000

CEO: Lonnel Coats

Employees: 285

Website: https://www.lexpharma.com/

LXRX News

ChartMill News Image3 days ago - ChartmillWhich stocks are moving on Friday?

Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

ChartMill News Image3 days ago - ChartmillTop movers in Friday's session

Intrigued by the market activity in the middle of the day on Friday? Uncover the key winners and losers of today's session in our insightful analysis.

ChartMill News Image4 days ago - ChartmillFriday's session: gap up and gap down stocks

Gapping stocks in Friday's session

ChartMill News Image4 days ago - ChartmillWhich stocks are moving before the opening bell on Friday?

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

News Image4 days ago - Lexicon Pharmaceuticals, Inc.Lexicon Announces Outcome of FDA Advisory Committee for Zynquistaâ„¢ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

PDUFA target action date set for December 20, 2024...

News Image5 days ago - Market News VideoNotable Wednesday Option Activity: SNOW, MDB, LXRX

LXRX Twits

Here you can normally see the latest stock twits on LXRX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example